KoBioLabs, Inc (KOSDAQ:348150)
South Korea · Delayed Price · Currency is KRW 3,435.00
+505.00 (17.24%)
At close: Jun 29, 2026
KoBioLabs Market Cap
KoBioLabs has a market cap or net worth of 66.7 billion as of June 29, 2026. Its market cap has decreased by -27.38% in one year.
Market Cap
66.70B
Enterprise Value
53.01B
Revenue
71.21B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,435.00
Market Cap Chart
Since November 18, 2020, KoBioLabs's market cap has decreased from 493.16B to 66.70B, a decrease of -86.47%. That is a compound annual growth rate of -29.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 29, 2026 | 66.70B | -40.05% |
| Dec 30, 2025 | 111.27B | 7.15% |
| Dec 30, 2024 | 103.84B | -35.34% |
| Dec 28, 2023 | 160.60B | -16.02% |
| Dec 29, 2022 | 191.23B | -42.95% |
| Dec 30, 2021 | 335.17B | -50.18% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ark Solutions | 68.91B |
| BIO-FD&C | 68.17B |
| CTCBIO | 66.23B |
| ADBiotech | 66.03B |
| QuadMedicine | 63.27B |
| Naturalendo Tech | 59.45B |
| PanGen Biotech | 58.52B |
| IMGT Co.,Ltd. | 56.24B |